Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries 2021-12-27 23:00
ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron 2021-12-27 21:20
I-Mab Announces IND Approval from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors 2021-12-27 21:00
Kintor Pharma Provides Update on One of its Three Multi-Regional Phase 3 Trials of Proxalutamide for COVID-19 2021-12-27 20:19
Brii Bio Doses First Patient in Phase 2a/2b Clinical Trial of BRII-179 (VBI-2601) for the Functional Cure of Chronic Hepatitis B 2021-12-27 18:45
COVID-19 Vaccine Developed by WestVac BioPharma Has High Titer Neutralizing Antibodies Against Omicron 2021-12-24 19:57
Innovent Announces NMPA of China Acceptance of a Supplemental New Drug Application for TYVYT® (Sintilimab Injection plus Bevacizumab Biosimilar Injection and Chemotherapy in Patients with EGFR-mutated Non-squamous Non-small Cell Lung Cancer who Progressed after EGFR-TKI Therapy 2021-12-24 16:51
Laekna Presents Vision and Strategy at NewYorkBIO/NYSE Emerging Company Showcase 2021-12-24 16:30
Convidecia™ Phase III Results Published in The Lancet 2021-12-24 15:28
Novavax and SK bioscience Expand Manufacturing Agreement 2021-12-24 07:30
Novo Nordisk BASEA office certified Best Place to Work for 2021 2021-12-23 21:37
Curocell, Breaks Ground on 'CAR-T Manufacturing GMP Facility' 2021-12-23 20:00
Ng Teng Fong Charitable Foundation Encourages COVID-19 Vaccination Amongst Elderly Citizens 2021-12-23 17:55
Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets 2021-12-23 16:23
Akeso's PCSK9 MONOCLONAL ANTIBODY (EBRONUCIMAB) EARLY COMPLETION OF PATIENT ENROLLMENT IN A PHASE III CLINICAL TRIAL FOR PRIMARY HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA 2021-12-23 12:42
Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China 2021-12-23 11:59
Global Recommendations for Colon Cancer Translated into Multiple Languages as NCCN Expands Arabic Resources 2021-12-23 09:17
Alphamab Oncology Announced First Patient Dosed in the U.S. in A Phase II Pivotal Clinical Study of KN046 2021-12-23 09:13
Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma 2021-12-23 09:00
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China 2021-12-23 07:44
1 303 304 305 306 307 896